Table 3.

CMR findings.

	Female controls n = 14	Female T2D patients n = 67	Male controls n = 16	Male T2D patients n = 62	p value
LV end-diastolic volume indexed to BSA, ml/m2	81 ± 13	73 ± 12	93 ± 19**	78 ± 12	<0.0001
LV mass index, g/m2	41 ± 6	43 ± 7	51 ± 14***	52 ± 8†	<0.0001
LV mass to LV end-diastolic volume, g/ml	0.50 ± 0.10	0.60 ± 0.11*	0.56 ± 0.11***	0.67 ± 0.13**,†	<0.0001
LV ejection fraction, %	60 ± 6	63 ± 7	59 ± 6	60 ± 6	NS
LA biplane end-systolic volumes, ml/m2	71 ± 16	70 ± 19	63 ± 16	72 ± 21	NS
Biplane LAEF, %	59 ± 10	59 ± 7	60 ± 8**	55 ± 6†	0.0094
Peak systolic circumferential strain, negative (–), %	23.5 ± 1.8	22.7 ± 2.8	19.1 ± 2.6***	20.5 ± 2.6†	<0.0001
Peak circumferential diastolic strain rate, s–1	1.41 ± 0.48	1.53 ± 0.31	1.26 ± 0.35	1.31 ± 0.35†	0.0005

Values are mean ± SD or percentages.

BSA, body surface area; CMR, cardiac magnetic resonance; LAEF, left atrial ejection fractions; LV, left ventricular; SD, standard deviation; T2D, type 2 diabetes.

^*p < 0.05 female T2D versus female controls, with Bonferroni Correction.

^†p < 0.05 female T2D versus male T2D, with Bonferroni Correction.

^**p < 0.05 male T2D versus male controls, with Bonferroni Correction.

^***p < 0.05 male versus female controls, with Bonferroni Correction.